10:43 AM EDT, 03/20/2026 (MT Newswires) -- Accenture's ( ACN ) fiscal Q2 financial results were solid and ahead of analyst expectations, but its fiscal Q3 guidance missed estimates, RBC Capital Markets analysts said in a Thursday note. Accenture ( ACN ) expects fiscal 2026 spending trends to remain similar to a year earlier, which RBC analysts note is a...

AIM ImmunoTech Inc. ( AIM ) shares slipped on Friday after more than doubling recently, following a sharp rally driven by final approval from the Japan Patent Office for its Ampligen-based cancer treatment. Patent Approval Details The newly approved Japanese patent covers Ampligen with anti-PD-1 or anti-PD-L1 inhibitors for cancer treatment. It includes multiple oncology applications, including pancreatic cancer, with...

Novartis AG ( NVS ) on Friday agreed to acquire a next-generation PI3Kα inhibitor program from Synnovation Therapeutics, aiming to strengthen its breast cancer pipeline with a more targeted and potentially better-tolerated treatment approach. • Novartis ( NVS ) stock is taking a breather. What should traders watch with NVS? Novartis Targets Next-Generation Breast Cancer Therapy The deal centers on...

11:11 AM EDT, 03/20/2026 (MT Newswires) -- American Eagle Gold ( AMEGF ) on Friday said it raised $23 million from a private-placement offering of 19.2-million flow-through shares at $1.20 each sold to mining magnate Eric Sprott. Sprott acquired the shares at a back-end price of $0.77, for a 9.9% equity stake in the company. He becomes the third strategic...